Lockheed Martin Or Northrop Grumman: Which Is The Better Buy?
Our answer: yes, on the business numbers Lockheed Martin is the stronger stock today, but the gap in valuation is far smaller than the gap in results. Lockheed’s total return over the year to Friday, Nov 13, was 34.1%; Northrop’s was 0.25%, while the S&P 500 ETF returned 13.5%. Yet on analysts’ 2027 earnings estimates the two trade at almost the same multiple: 17.9 times for Lockheed and 18.4 times for Northrop.
That is the surprise. After a year in which one stock returned 34.1% and the other 0.25%, the winner is not the expensive one on next year’s earnings. Lockheed closed at $596.04 on Friday, down 2.3% since our Nov 11 piece. Northrop closed at $550.43, 28.3% below its March 2 high.

Where Lockheed pulls ahead
Start with growth. Lockheed’s third-quarter revenue grew 11.3% from a year earlier, against 6.7% at Northrop. Lockheed ended the quarter with a record backlog of $292 billion, up $113 billion in a year. That order book equals 3.7 years of its trailing revenue. Northrop’s record $110 billion backlog covers 2.5 years.
Then guidance. On Oct 22 Lockheed raised its 2026 targets for sales, to $80.0-$82.0 billion, for earnings per share, to $30.35-$30.75, and for free cash flow, to $7.8-$8.0 billion from $7.1 billion. The stock rose 7.0% that day. Northrop, two days earlier, affirmed its sales guidance of $43.75-$44.25 billion and its adjusted free cash flow guidance of $3.1-$3.5 billion. It did raise its segment operating income guidance, and it raised its EPS guidance by $0.70 a share. For more on what drove Lockheed’s raise, see what Lockheed Martin holders should take from its third-quarter report.
Analysts see the same split. Consensus expects Lockheed’s EPS to grow 8.6% from 2026 to 2027, against 0.60% for Northrop.
And cash returned. Lockheed’s dividend yields 2.4%, against 1.8% for Northrop. Lockheed’s free cash flow guidance midpoint equals 5.7% of its market value; Northrop’s adjusted free cash flow guidance midpoint equals 4.2% of its own. Why that cash yield matters is covered in why Lockheed Martin’s high cash yield gets ignored.
| Measure | LMT | NOC |
|---|---|---|
| Total return, year to Nov 13 | 34.1% | 0.25% |
| Q3 revenue growth | 11.3% | 6.7% |
| Backlog, years of revenue | 3.7 | 2.5 |
| Price / trailing EPS | 21.2x | 17.4x |
| Price / 2027 consensus EPS | 17.9x | 18.4x |
| Dividend yield | 2.4% | 1.8% |
| Below March 2 high | 11.9% | 28.3% |
The case for Northrop
On earnings already reported, Northrop is the cheaper stock: 17.4 times trailing EPS against 21.2 times for Lockheed. That trailing figure leans on a strong fourth quarter of 2025, when Northrop earned $9.96 a share, which is why the gap closes on 2027 estimates.
Northrop also has more room to recover if its plan shows up. It sits 28.3% below its high, while Lockheed is 11.9% below its own. On its third-quarter call Northrop projected sales growth of 5% to 7% for 2027, faster than this year. It also expects 2027 adjusted free cash flow of $3.3 billion to $3.7 billion. If it delivers, we think the market would have reason to reprice a stock that went nowhere for a year.
The balance sheet is the other point. Northrop’s stockholders’ equity was $18,683 million at Sep 30, against $10,063 million at Lockheed at Sep 27, although Lockheed is the larger company by market value. Northrop’s net debt was $12,891 million, against $14,538 million at Lockheed.
Where Northrop’s business is weakest is a separate question; our memo to Northrop Grumman’s space systems team looks at satellite launches.
What an investor can do this week
For someone choosing one defense prime, the numbers favor Lockheed Martin: faster growth, a longer order book, a raise to its sales and free cash flow guidance, and a higher dividend, at about the same multiple of 2027 estimates. The risk is that much of this is already in the price after a 34.1% year; if Lockheed’s growth slows toward Northrop’s, the stock has further to fall than a laggard sitting 28.3% below its high.
A reader who already owns Northrop does not have to switch to act on this. The test to watch is whether Northrop’s stated 2027 sales growth target shows up in its next reports. If it does, the gap between the two stocks’ returns looks too wide; if it does not, Lockheed’s lead is earned.
The idea underneath is simple: a stock that has beaten its rival is not automatically the expensive one. Measure both on what they are expected to earn next, not on how they have traded.
Which defense stock fits your portfolio better?
If you have $1 million or more invested, see what this means for your portfolio in a free 15-minute call with a Trefis partner firm.
For questions about this article or underlying research, email help@trefis.com.